Anacor Pharmaceuticals, Inc. (ANAC) saw shares advancing 25.62% or $1.24 per share to close Friday at $6.08 on volume of 7,467,933 shares traded. Shares of Anacor Pharmaceuticals Inc. jumped for the second consecutive after the company reported strong data from a clinical trial of a drug intended to treat a type of chronic rash. Anacor is testing a topical drug called AN2728 as a treatment for atopic dermatitis, a chronic rash that causes inflammation and itching. Will last week's gains continue over to start the new week or will profit takers put a halt to the big gains? Find out our thoughts in our exclusive report at: http://squawkboxstocks.com/reports/ANAC
TIBCO Software Inc. (TIBX) saw shares declining 9.41% or $2.18 per share to close Friday at $20.99 on volume of 24,572,931 shares traded. On Thursday, the enterprise software company reported Q1 revenue that missed views, as did its earnings outlook for the current quarter. Tibco reported earnings per share minus items of 18 cents, down 10% from the year-earlier quarter and its first year-over-year profit decline since at least August 2008. Revenue fell 5% to $237.8 million, where analysts polled by Thomson Reuters had expected $242.4 million. Following this disappointing earnings report will shares of TIBX continue to trade lower this week or is a bottom in sight? Find out our thoughts in our exclusive TIBX report at: http://squawkboxstocks.com/reports/TIBX
Groupon, Inc. (GRPN) saw shares advancing 5.90% or $0.32 per share to close at $5.74 on volume of 16,979,605 shares traded during Friday's trading session. A $5 deal for food and beverages at Starbucks propelled Groupon shares to nearly $6 on Friday even as the bargain offering overloaded the company's website. Will shares of Groupon, Inc. continue to rally higher seeing the daily deal companies popularity with consumers? Find out our thoughts in our exclusive report at: http://squawkboxstocks.com/reports/GRPN
Arena Pharmaceuticals, Inc. (ARNA) saw shares advancing 6.20% to close Friday's trading session at $8.39 on volume of 10,442,424 shares traded. The biopharmaceutical company saw total gains of 8.20% during the last three days of last week. This came after a longer downtrend took shares below the bottom level of its seven month trend. Will shares of Arena Pharmaceuticals, Inc. continue their rally to start the week or will profit takers come in to put a halt to the recent winning streak? Find out more in our exclusive report at: http://squawkboxstocks.com/reports/ARNA
Squawk Box Stocks offers its daily stock alerts and market content newsletter to investors looking for timely information available! Our experienced team provides you only the best stock alerts & research reports delivered to your email inbox for FREE. Our track record of providing winning alerts has won us the trust of thousands of investors worldwide. With our dedicated research team & investor database continuing to grow we have become a leading destination for the most profitable opportunities that are available in today's stock market. To receive our FREE, comprehensive newsletter, visit http://SquawkBoxStocks.com.
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.
A third party, Winning Media LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.
Winning Media LLC